Philosys Healthcare Rises 26.56% Amid COVID-19 (Plasma Therapy/Plasma Therapeutics) Theme Uptrend

On the 20th, the COVID-19 (plasma treatment/plasma therapy) theme rose by 3.16% compared to the previous day, showing strength, while Philosis Healthcare, a related stock drawing attention, surged by 26.56% compared to the previous day. Philosis Healthcare is known as a specialized manufacturer of digital set-top boxes.

[Graph] Major stock price changes in the COVID-19 (plasma treatment/plasma therapy) theme

According to the analysis by Thinkpool Robo Algorithm RASSI, Philosis Healthcare's quant financial score was 13.44 points, ranking 8th in the quant financial ranking within the COVID-19 (plasma treatment/plasma therapy) related theme. This can be interpreted as Philosis Healthcare having relatively low investment attractiveness from a financial perspective. On the other hand, S-Mac ranked first in the quant financial ranking with higher growth, stability, and profitability scores compared to the average of other stocks.

[Table] Top stocks by financial score within the theme

※ The quant financial score is the result of Robo Algorithm's analysis based on each company's sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist Thinkpool.

This content was produced with the assistance of AI translation services.